T. Emil Kuriakose's most recent trade in Terns Pharmaceuticals Inc was a trade of 853 Common Stock done at an average price of $4.3 . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals Inc | T. Emil Kuriakose | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.27 per share. | 01 Jul 2025 | 853 | 52,464 | - | 4.3 | 3,640 | Common Stock |
| Terns Pharmaceuticals Inc | Emil T. Kuriakose | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.49 per share. | 01 Apr 2025 | 952 | 53,317 | - | 2.5 | 2,366 | Common Stock |
| Terns Pharmaceuticals Inc | Emil T. Kuriakose | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 485,000 | 485,000 | - | - | Stock Option (Right to Buy) | |
| Terns Pharmaceuticals Inc | Emil T. Kuriakose | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.71 per share. | 02 Jan 2025 | 4,481 | 54,269 | - | 5.7 | 25,607 | Common Stock |
| Terns Pharmaceuticals Inc | Emil T. Kuriakose | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) |